Recently, Pri Pharmaceuticals received a marketing license for injectable ganciclovir issued by the Guatemalan National Drug Administration, which indicates that the injectable ganciclovir produced by Pri Pharmaceuticals is eligible to be marketed and sold in Guatemala.

Recently, Pri Pharmaceuticals received a marketing license for injectable ganciclovir issued by the Guatemalan National Drug Administration, which indicates that the injectable ganciclovir produced by Pri Pharmaceuticals is eligible to be marketed and sold in Guatemala.